MONOCLONAL-ANTIBODIES TO HUMAN-MALIGNANT MESOTHELIOMA

被引：29

作者：

ANDERSON, TM

HOLMES, EC

KOSAKA, CJ

CHENG, L

SAXTON, RE

机构：

[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT SURG,DIV SURG ONCOL,LOS ANGELES,CA 90024

[2] UNIV CALIF LOS ANGELES,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90024

来源：

关键词：

D O I：

10.1007/BF00915731

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：254 / 261

页数：8

共 18 条

[1] ANDERSON TM, 1986, P AM ASSOC CANC RES, V27, P31
[2] STUDIES OF A HUMAN MESOTHELIOMA
BEHBEHANI, AM
HUNTER, WJ
CHAPMAN, AL
LIN, F
[J]. HUMAN PATHOLOGY, 1982, 13 (09) : 862 - 866
[3] HOLLAND JF, 1979, P AM ASS CANCER RES, V20, P62
[4] Kennett R. H., 1980, MONOCLONAL ANTIBODIE, P376
[5] LAMPSON LA, 1980, MONOCLONAL ANTIBODIE, P395
[6] USE OF ANTIBODIES TO CARCINOEMBRYONIC ANTIGEN AND HUMAN-MILK FAT GLOBULE TO DISTINGUISH CARCINOMA, MESOTHELIOMA, AND REACTIVE MESOTHELIUM
MARSHALL, RJ
HERBERT, A
BRAYE, SG
JONES, DB
[J]. JOURNAL OF CLINICAL PATHOLOGY, 1984, 37 (11) : 1215 - 1221
[7] MENNEMEYER R, 1979, CANCER, V44, P692, DOI 10.1002/1097-0142(197908)44:2<692::AID-CNCR2820440242>3.0.CO
[8] 2-6
[9] MOORE JH, 1980, CANCER, V45, P2395, DOI 10.1002/1097-0142(19800501)45:9<2395::AID-CNCR2820450926>3.0.CO
[10] 2-5